BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32737711)

  • 1. Should we be talking about guidelines with patients? A qualitative analysis in metastatic breast cancer.
    Hull O; Niranjan SJ; Wallace AS; Williams BR; Turkman YE; Ingram SA; Williams CP; Smith T; Knight SJ; Bhatia S; Rocque GB
    Breast Cancer Res Treat; 2020 Nov; 184(1):115-121. PubMed ID: 32737711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What Is Important When Making Treatment Decisions in Metastatic Breast Cancer? A Qualitative Analysis of Decision-Making in Patients and Oncologists.
    Rocque GB; Rasool A; Williams BR; Wallace AS; Niranjan SJ; Halilova KI; Turkman YE; Ingram SA; Williams CP; Forero-Torres A; Smith T; Bhatia S; Knight SJ
    Oncologist; 2019 Oct; 24(10):1313-1321. PubMed ID: 30872466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "I'd Want to Know, Because a Year's Not a Long Time to Prepare for a Death": Role of Prognostic Information in Shared Decision Making among Women with Metastatic Breast Cancer.
    Niranjan SJ; Turkman Y; Williams BR; Williams CP; Halilova KI; Smith T; Knight SJ; Bhatia S; Rocque GB
    J Palliat Med; 2020 Jul; 23(7):937-943. PubMed ID: 32043896
    [No Abstract]   [Full Text] [Related]  

  • 4. Trust but Verify: Exploring the Role of Treatment-Related Information and Patient-Physician Trust in Shared Decision Making Among Patients with Metastatic Breast Cancer.
    Niranjan SJ; Wallace A; Williams BR; Turkman Y; Williams CP; Bhatia S; Knight S; Rocque GB
    J Cancer Educ; 2020 Oct; 35(5):885-892. PubMed ID: 31062280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How oncologists communicate information to women with recurrent ovarian cancer in the context of treatment decision making in the medical encounter.
    Elit LM; Charles C; Gafni A; Ranford J; Tedford-Gold S; Gold I
    Health Expect; 2015 Oct; 18(5):1066-80. PubMed ID: 23663240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is There a Relationship between Shared Decision Making and Breast Cancer Patients' Trust in Their Medical Oncologists?
    Engelhardt EG; Smets EMA; Sorial I; Stiggelbout AM; Pieterse AH; Hillen MA
    Med Decis Making; 2020 Jan; 40(1):52-61. PubMed ID: 31789100
    [No Abstract]   [Full Text] [Related]  

  • 7. Shared decision making in oncology: A model based on patients', health care professionals', and researchers' views.
    Bomhof-Roordink H; Fischer MJ; van Duijn-Bakker N; Baas-Thijssen MC; van der Weijden T; Stiggelbout AM; Pieterse AH
    Psychooncology; 2019 Jan; 28(1):139-146. PubMed ID: 30346076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncologist-Reported Barriers and Facilitators to Enrolling Patients in Optimization Trials That Test Less Intense Cancer Treatment.
    Rocque GB; Andrews C; Lawhon VM; Frazier R; Ingram SA; Smith ML; Wagner LI; Zubkoff L; Tung N; Wallner LP; Wolff AC
    JCO Oncol Pract; 2023 Feb; 19(2):e263-e273. PubMed ID: 36473142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of personalizing medicine: medical oncologists' views on gene expression profiling in breast cancer treatment.
    Bombard Y; Rozmovits L; Trudeau M; Leighl NB; Deal K; Marshall DA
    Oncologist; 2015 Apr; 20(4):351-6. PubMed ID: 25746345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shared decision making about palliative chemotherapy: A qualitative observation of talk about patients' preferences.
    Henselmans I; Van Laarhoven HW; Van der Vloodt J; De Haes HC; Smets EM
    Palliat Med; 2017 Jul; 31(7):625-633. PubMed ID: 28618897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients' Preferences for Information About the Benefits and Risks of Second-Line Palliative Chemotherapy and Their Oncologist's Awareness of These Preferences.
    Oostendorp LJ; Ottevanger PB; van de Wouw AJ; Honkoop AH; Los M; van der Graaf WT; Stalmeier PF
    J Cancer Educ; 2016 Sep; 31(3):443-8. PubMed ID: 25985960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of quality-of-life priorities and preferences surrounding treatment decision making in patients with cancer and oncology clinicians.
    Williams CP; Miller-Sonet E; Nipp RD; Kamal AH; Love S; Rocque GB
    Cancer; 2020 Aug; 126(15):3534-3541. PubMed ID: 32426870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic communication about lung cancer in the precision oncology era: A multiple-perspective qualitative study.
    Petrillo LA; Shimer SE; Zhou AZ; Sommer RK; Feldman JE; Hsu KE; Greer JA; Traeger LN; Temel JS
    Cancer; 2022 Aug; 128(16):3120-3128. PubMed ID: 35731234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decision making in pediatric oncology: Views of parents and physicians in two European countries.
    Badarau DO; Ruhe K; Kühne T; De Clercq E; Colita A; Elger BS; Wangmo T
    AJOB Empir Bioeth; 2017; 8(1):21-31. PubMed ID: 28949870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "It's important to me": A qualitative analysis on shared decision-making and patient preferences in older adults with early-stage breast cancer.
    Lawhon VM; England RE; Wallace AS; Williams CP; Williams BR; Niranjan SJ; Ingram SA; Rocque GB
    Psychooncology; 2021 Feb; 30(2):167-175. PubMed ID: 32964517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Often Relatives are the Key […]" -Family Involvement in Treatment Decision Making in Patients with Advanced Cancer Near the End of Life.
    Laryionava K; Hauke D; Heußner P; Hiddemann W; Winkler EC
    Oncologist; 2021 May; 26(5):e831-e837. PubMed ID: 33037846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ONCOLOGISTS' BARRIERS AND FACILITATORS FOR ONCOTYPE DX USE: QUALITATIVE STUDY.
    Roberts MC; Bryson A; Weinberger M; Dusetzina SB; Dinan MA; Reeder-Hayes K; Wheeler SB
    Int J Technol Assess Health Care; 2016 Jan; 32(5):355-361. PubMed ID: 27958190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of priority setting decisions for new cancer drugs on medical oncologists' practice in Ontario: a qualitative study.
    Berry SR; Hubay S; Soibelman H; Martin DK
    BMC Health Serv Res; 2007 Nov; 7():193. PubMed ID: 18042302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How Does a Shared Decision-Making (SDM) Intervention for Oncologists Affect Participation Style and Preference Matching in Patients with Breast and Colon Cancer?
    Bieber C; Nicolai J; Gschwendtner K; Müller N; Reuter K; Buchholz A; Kallinowski B; Härter M; Eich W
    J Cancer Educ; 2018 Jun; 33(3):708-715. PubMed ID: 27966192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "I need to know what makes somebody tick …": Challenges and Strategies of Implementing Shared Decision-Making in Individualized Oncology.
    Haltaufderheide J; Wäscher S; Bertlich B; Vollmann J; Reinacher-Schick A; Schildmann J
    Oncologist; 2019 Apr; 24(4):555-562. PubMed ID: 30190300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.